HLS vs NUZ

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

49LOW

NUZ

NEURITHERA FPO [NUZ]

49LOW

Score Breakdown

HLS NUZ
Technical
50
48
Catalyst
61
51
Sentiment
50
50
Fundamental
91
48
Momentum
37
45
Risk Gate
32
50

Key Metrics

HLS Metric NUZ
$415.3MMarket Cap$56.7M
3.5MAvg Volume (20d)695K
+6.3%Short InterestN/A
$1.63552-Week High$0.185
$0.55752-Week Low$0.076
-0.5%Daily Change+0.0%
$0.572Entry Price$0.080
-69.3%ROE-147.1%
-12.3%Profit Margin-248.4%

Active Signals

HLS Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.3x)
EPS estimates revised upward (+10pts)
Near 52-week low (1% of range)

NUZ Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Drifting lower — down 4.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.8 quarters)
Moderate P/S ratio (9.5x)
Strong revenue growth (+290%)

Ask Scout AI to compare HLS and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HLS Full Analysis → NUZ Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).